New technologies have led to tremendous progress in understanding what toda
y we call bipolar disorders, whose clinical diagnosis has been refined cont
inuously since Kraepelin first described them. Molecular genetic studies ha
ve produced interesting findings, but to date have failed to identify speci
fic genes that are so far responsible for the vulnerability to bipolar. dis
orders. Biochemical studies in combination with pharmacotherapy give hints
that the neurotransmitter function and the related signal transduction may
be abnormally regulated. Since all the neurotransmitter circuits are interc
onnected, the dysregulation may occur on different levels and it is rather
improbable that one single abnormality should account for the disorder. Thi
s paper reviews these promising developments. (C) 2001 Elsevier Science B.V
. All rights reserved.